Signing of an agreement by Dr. Kimberly Cline, President of Long Island University and Mr. Antoine Turzi, President of RegenLab USA LLC, for the creation of an industrial innovation accelerator dedicated to cell therapies and tissue engineering integrated into the “Dassault Systèmes Center of Excellence” Establishment of a teaching program with Long Island University, with […]
On May 19, Shimadzu Corporation has invested in ChromaCode Inc. (ChromaCode), a startup with technology to expand genetic testing, through its corporate venture capital (CVC) fund, Shimadzu Future Innovation Fund L.P. (Shimadzu FIF). This is Shimadzu FIF’s first investment. ChromaCode is a startup that expands the number of target genes available in existing PCR with […]
News Summary: Integration of Sartorius’ process scale multi-column chromatography with Waters’ process analytical technology to provide robust analytical data for downstream biomanufacturing of mAbs, recombinant proteins, vaccines, and other biologics. Integrated solution to deliver vital analytical data in days, not weeks – and to reduce waste and help lower drug production costs. Bioprocess scientists will […]
As a leader in data-driven medicine, SOPHiA GENETICS lends its expertise to support White House Cancer Moonshot BOSTON and LAUSANNE, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, announced today at ASCO that it has joined as a founding member of CancerX, a new public-private partnership […]
Invivoscribe and Complete Genomics announced today that they had entered a partnership to develop and commercialize biomarker tests on Complete Genomics’ NGS platforms. The territory is worldwide, and the field is oncology and cancer research. Under the terms of the deal, Invivoscribe will be responsible for the development of biomarker tests, including test controls and […]
– Cutting-edge spatial omics technologies to map cancer cells and their immune environment in high resolution, allowing AI to unlock potential for new breakthrough treatments – – Landmark research project is 100x larger than existing efforts – – Data will be generated from thousands of patients across multiple cancers – – University of Pittsburgh, Gustave Roussy, Lausanne University Hospital, […]
ERS Genomics & abm enter into CRISPR/Cas9 Licensing Agreement This License allows abm to develop and commercialize products using CRISPR/Cas9 technology. Dublin, Ireland and Vancouver, Canada, 1st June 2023: ERS Genomics Limited (‘ERS’) is pleased to announce a new license agreement with Applied Biological Materials Inc (‘abm,’). This is a non-exclusive licensing agreement granting abm access to the ERS CRISPR/Cas9 […]
MUNICH, Germany and TEL AVIV, Israel — NurExone Biologic Inc. (the “Company” or “NurExone”) NRX (FSE: J90), a biopharmaceutical company developing biologically-guided exosome therapy (“ExoTherapy”) for patients with traumatic spinal cord injuries, is pleased to announce a pioneering collaboration with the German company, Particle Metrix, a leading provider of particle analysis devices. In connection with […]
The companies agree to a worldwide Human Platelet Lysate (HPL) Patent License and Assignment Agreement, including redirection of HPL customers from Macopharma to PL BioScience. AACHEN, Germany — PL BioScience GmbH, a German life science company specializing in the production and development of Human Platelet Lysate (HPL) for cell expansion, today announced a Patent License […]
NANJING, China — Vazyme (688105.SH), China’s leading biotechnology company, has officially signed a global strategic cooperation agreement with Azenta Life Sciences (“Azenta”, Nasdaq: AZTA), which will promote to establish “one-stop” service process for both companies in the fields of next-generation sequencing, automated library preparation, raw material supply, experimental consumables, sample storage and more. Dr. Nie Junwei, General Manager of […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
